A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Clinical trial NCT05379595 · RECRUITING
Trial details
- NCT number
- NCT05379595
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-29
- Primary completion
- 2027-04-27
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.